The relationship between the FTO gene and menopause (Wechseljahre) is not well-established. FTO (Fat Mass and Obesity Associated) is primarily linked to body weight regulation and fat metabolism. Variants in this gene are associated with increased obesity risk. Since body fat and obesity can influence hormonal balance and the timing of menopause, an indirect link is plausible. Some studies suggest that certain FTO variants may be associated with earlier menopause onset, but effect sizes are small and evidence is inconsistent. Consumer DNA tests (e.g., from MyBody-X) can detect these variants, but their clinical utility for predicting menopause is very limited. Menopause timing is influenced by many genetic, hormonal, and lifestyle factors. A single gene test cannot predict when menopause will occur or how symptoms will manifest. Caution is warranted: results may cause unnecessary concern without actionable insights. In summary, the FTO–menopause connection is weak and indirect; evidence is based on observational studies, not clinical practice.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-380c9244df2f761ca3c70947